CompletedNCT00835107
Ziprasidone and sleep patterns in bipolarity-related depression
About this title
Read the official source — NCT00835107Medication studyAges 18+Canada
Understand this study
Who was this study for?
Listed age limits: from 18 years.
- Listed locations
- KingstonSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateFebruary 2009
- Recruitment status
- Completed
- Enrollment listed in the registry
- 14
- Sponsor
- Queen's University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- Canada
- Age range
- Over 18 Years
- Official registry ID
- NCT00835107
- Official title
Show the full official title
An Investigation of Sleep Architecture in Ziprasidone-Treated Bipolar Depression
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedKingston
Questions about this study
Who is behind this study?
The study sponsor is Queen's University, a university.
Did this study involve medication?
Yes. The study involved medication, including ziprasidone hydrochloride and placebo.
Who was this study for?
Listed age limits: from 18 years.
